We are live on ! Find out more
THRD

Third Harmonic Bio
THRD

Delisted

THRD was delisted on the 30th of July, 2025.

Back to rankings

76 hedge funds and large institutions have $523M invested in Third Harmonic Bio in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

46% more capital invested

Capital invested by funds: $358M → $523M (+$166M)

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

7% more funds holding

Funds holding: 71 → 76 (+5)

5.23% more ownership

Funds ownership: 93.05% → 98.28% (+5.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
76
Holders Change
+5
Holders Change %
+7.04%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
30
Reduced
16
Closed
11
Calls
$118K
Puts
–
Net Calls
+$118K
Net Calls Change
+$118K

Top Buyers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$16.7M
2
Citadel Advisors
Citadel Advisors
Florida
+$8.42M
3
CC
Commodore Capital
New York
+$3.65M
4
Invesco
Invesco
Georgia
+$3.35M
5
SSA
Schonfeld Strategic Advisors
New York
+$1.49M

Top Sellers

1
JP Morgan Chase
JP Morgan Chase
New York
-$5.3M
2
Millennium Management
Millennium Management
New York
-$1.9M
3
BCM
Bridgeway Capital Management
Texas
-$425K
4
Goldman Sachs
Goldman Sachs
New York
-$391K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$289K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$142M – – –
O
2
OrbiMed
New York
$75.1M – – –
BI
3
BVF Inc
California
$56.8M – – –
EC
4
EcoR1 Capital
California
$41.4M – – –
GA
5
General Atlantic
New York
$38.5M – – –
RCM
6
RA Capital Management
Massachusetts
$26.4M – – –
BC
7
Boxer Capital
California
$26M – – –
CC
8
Commodore Capital
New York
$20.1M +$3.65M +295,426 +24%
BlackRock
9
BlackRock
New York
$18.6M +$814K +65,778 +5%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$17.5M +$16.7M +1,349,234 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$11.4M +$277K +22,404 +3%
Citadel Advisors
12
Citadel Advisors
Florida
$8.85M +$8.42M +680,768 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$5.62M +$401K +32,409 +8%
State Street
14
State Street
Massachusetts
$5.02M +$67.9K +5,488 +1%
SSA
15
Schonfeld Strategic Advisors
New York
$4.29M +$1.49M +120,750 +58%
Invesco
16
Invesco
Georgia
$3.52M +$3.35M +270,989 New
SCM
17
Sio Capital Management
New York
$2.12M – – –
Northern Trust
18
Northern Trust
Illinois
$1.98M -$44.7K -3,612 -2%
Charles Schwab
19
Charles Schwab
California
$1.79M +$84.8K +6,857 +5%
PHP
20
Parkman Healthcare Partners
Connecticut
$1.73M +$1.15M +93,325 +233%
Morgan Stanley
21
Morgan Stanley
New York
$1.66M -$30.3K -2,447 -2%
Renaissance Technologies
22
Renaissance Technologies
New York
$1.43M +$518K +41,900 +61%
Millennium Management
23
Millennium Management
New York
$1.33M -$1.9M -153,365 -60%
Wellington Management Group
24
Wellington Management Group
Massachusetts
$1.18M +$82.9K +6,703 +8%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$801K +$91.2K +7,373 +14%
1
2 3 4

THRD Hedge Fund Activity: Q2 2024 in Review

76 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q2 2024, worth a combined $523M — up 46% from $358M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new THRD positions and 11 closed out — a net gain of 5 holders — while 30 added to existing stakes and 16 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $16.7M. The largest seller was JP Morgan Chase, cutting an estimated $5.3M.

  • 76 institutional investors held Third Harmonic Bio (THRD) as of Q2 2024, up from 71 in Q1 2024.
  • Funds reported $523M of Third Harmonic Bio stock for Q2 2024, up 46% quarter-over-quarter.
  • 16 funds opened new Third Harmonic Bio positions in Q2 2024 and 11 closed out, a net change of +5 holders.
  • The largest Third Harmonic Bio buyer in Q2 2024 was T. Rowe Price Investment Management, an estimated $16.7M added.
  • The largest Third Harmonic Bio seller in Q2 2024 was JP Morgan Chase, an estimated $5.3M sold.

Based on aggregated 13F filings for Q2 2024.